Drug Shortage Report for SANDOZ ABIRATERONE

Last updated on 2025-05-12

Report ID 254329
Drug Identification Number 02486393
Brand name SANDOZ ABIRATERONE
Common or Proper name ABIRATERONE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ABIRATERONE ACETATE
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 120TAB
ATC code L02BX
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2025-04-07
Estimated end date 2025-05-16
Actual end date 2025-05-12
Shortage status Actual shortage
Updated date 2025-05-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2025-05-12 French Compare
v10 2025-05-12 English Compare
v9 2025-05-05 French Compare
v8 2025-05-05 English Compare
v7 2025-04-22 French Compare
v6 2025-04-22 English Compare
v5 2025-04-14 French Compare
v4 2025-04-14 English Compare
v3 2025-04-08 English Compare
v2 2025-04-07 French Compare
v1 2025-04-07 English Compare

Showing 1 to 11 of 11